Avery Dennison Corporation

Avery Dennison's filings describe a company rebuilding volume and margin after a near-flat 2025, but the numbers support a mixed reading. Revenue for 2025 was $8.86 billion, up 1.1% from $8.76 billion, while net income fell to $688 million from $704.9 million. Operating cash flow of $881.4 million covered net income about 1.28 times, but it was down from $938.8 million in 2024. The forensic scores point in different directions. The Beneish M-Score of -2.549 is below the -1.78 threshold and sits outside the elevated manipulation-risk zone; that is a screening result, not proof that the reporting is clean. The Altman Z″-Score of 3.49 is in the safe zone, meaning the model does not flag near-term distress. The Piotroski F-Score is 5 of 9 computable signals, a mid-range count that shows neither broad strength nor broad weakness across the profitability, leverage and efficiency checks it uses. The Fog Index of 17.16 falls in the hard-to-read band, which matters because the 2026 cash and restructuring explanations sit in dense text. On the business side, the risk factors tie results to tariffs on goods from Canada, Mexico, China and the European Union, the U.S. Supreme Court's February 20, 2026 IEEPA ruling, and emerging-market exposure, with about 40% of 2025 net sales from those markets. Management says direct tariff effects have not been significant after mitigating actions, though indirect demand effects remain uncertain. Readers may want to look at the working-capital and incentive-compensation discussion in the 10-Q cash flow section alongside the 10-K balance sheet, where debt rose to $3.2 billion from $2.55 billion.

Catalyst.Management's 2026 story is volume-led growth and cost recovery. In the six months ended June 30, 2026, net sales rose 9% (6% excluding currency, 4% organic), with the company citing higher volume partly offset by unfavorable mix and raw-material deflation price reductions. Second-quarter net sales reached $2,462.9 million versus $2,220.5 million, and net income for the first six months rose to approximately $372 million from approximately $355 million. The filing credits productivity gains from restructuring, a net pricing and raw-material benefit, and favorable currency translation. The 2026 outlook also flags higher interest expense and a full-year effective tax rate in the high-twenty percent range.

Hidden risk.The largest tension is between the cash-flow rebound and its sources. Operating cash flow for the first six months of 2026 rose to $544.7 million from $192.5 million, but management attributes the increase primarily to changes in operational working capital and lower incentive compensation payments, both of which can reverse. Full-year 2025 operating cash flow was $881.4 million, down from $938.8 million in 2024, while long-term debt climbed from $2.55 billion to $3.2 billion after the €500 million of senior notes issued in September 2025. Restructuring continues, with $34.7 million recorded in the first half of 2026 tied to about 600 positions. The risk factors also note that about 69% of 2025 net sales originated outside the U.S.